SageView Advisory Group »

Cartesian Therapeutics shares owned by SageView Advisory Group

Quarter-by-quarter ownership of Cartesian Therapeutics (RNAC) shares owned by SageView Advisory Group from 13F filings

Historical chart of SageView Advisory Group investment in Cartesian Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cartesian Therapeutics held by SageView Advisory Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cartesian Therapeutics by SageView Advisory Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $21 3 7.33

More positions owned by SageView Advisory Group

Ishares Tr Core Us Aggbd Et (AGG)
Vanguard Scottsdale Fds Vng Rus1000val (VONV)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Schwab Strategic Tr Intl Eqty Etf (SCHF)
Vanguard Index Fds Extend Mkt Etf (VXF)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Ishares Tr Core Intl Aggr (IAGG)
Ishares Tr Global Reit Etf (REET)
Schwab Strategic Tr Intl Sceqt Etf (SCHC)
Apple (AAPL)
Spdr Series Trust State Street Spd (SPHY)
Ishares Tr National Mun Etf (MUB)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)

View all positions for SageView Advisory Group

Top funds holding Cartesian Therapeutics

FMR
BlackRock
Vanguard Group
683 Capital Management
Erste Asset Management GmbH
Geode Capital Management
State Street Corporation
Marshall Wace
Privium Fund Management B.V.
Jacobs Levy Equity Management
Northern Trust
Citadel Advisors
GSA Capital Partners
UBS Group
Susquehanna International

View all funds holding Cartesian Therapeutics